title: Treating epilepsy in the elderly: safety considerations.
abstract: The incidence of epilepsy increases with advancing age. Epilepsy in the elderly has different aetiologies from that in younger populations, cerebrovascular disease being the most common condition associated with seizures. Partial seizures are the predominant seizure type in older patients. A diagnosis of epilepsy in the elderly is based mainly on the history and is frequently delayed. In addition, seizure imitators are especially frequent. In many cases ancillary tests for diagnosis may show normal age-related variants, sometimes making results difficult to interpret. Treating epilepsy in the elderly is problematic due to a number of issues that relate to age and comorbidity. The physical changes associated with increasing age frequently lead to changes in the pharmacokinetics of many anticonvulsants. The treatment of epilepsy in the elderly is also complicated by the existence of other diseases that might affect the metabolism or excretion of anticonvulsants and the presence of concomitant medications that might interact with them. Moreover, specific trials of anticonvulsants in the aged population are scarce. General guidelines for treatment include starting at lower doses, slowing the titration schedule, individualising the choice of anticonvulsant to the characteristics of the patient, avoiding anticonvulsants with important cognitive or sedative adverse effects, and where possible, treating with monotherapy.
authors.affiliation: Epilepsy Unit, Hospital Clínico de Barcelona, Barcelona, Spain.
authors.forename: S
authors.initials: S
authors.lastname: Arroyo
authors.forename: G
authors.initials: G
authors.lastname: Kramer
mesh_terms: D000368:Aged; D000927:Anticonvulsants / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004827:Epilepsy / Q000150:complications* / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans
chemical_list: D000927:Anticonvulsants